Skip to main content

Cardlytics Inc

For the period ended Dec 31, 2023. Filed Mar 14, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 14, 2024

CDLX$1.82-6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 9B. Other Information

On March 12, 2024, Jessica Jensen and Aimée Lapic each provided notice to our board of directors (the “Board”) of their decision not to stand for re-election to the Board at our 2024 annual meeting of stockholders (the “Annual Meeting”). Ms. Jensen and Ms. Lapic will each serve out the remainder of their terms, which will expire at the Annual Meeting. Ms. Jensen is a member of the compensation committee (the “Compensation Committee”) of the Board and has served as a member of the Board since 2020. Ms. Lapic is chair of the Compensation Committee and has served as a member of the Board since 2019. The decisions of Ms. Jensen and Ms. Lapic not to stand for re-election were not due to a disagreement with us on any matter relating to our operations, policies or practices. The Board thanks Ms. Jensen and Ms. Lapic for their contributions to the company.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.